HEPATIC MORPHOFUNCTIONAL ALTERATIONS IN EXPERIMENTAL UROLITHIASIS UNDER ENVIRONMENTAL EXPOSURE: PATHOGENETIC LINKS AND PROSPECTS FOR BIOCORRECTION

Authors

Keywords:

experimental urolithiasis; nephrolithiasis; liver histology; hepatocyte morphometry; oxidative stress; environmental exposure; biocorrection; kidney–liver axis.

Abstract

Experimental urolithiasis is widely used to investigate renal crystal deposition, oxidative injury, and inflammatory responses. However, whether and to what extent lithogenic injury produces reproducible hepatic morphological alterations, particularly under additional environmental exposure, remains insufficiently established. This narrative review synthesizes plausible kidney–liver interactions and develops a transparent morphofunctional assessment framework based on a doctoral research proposal. Relevant endpoints include hepatocyte morphology, sinusoidal dimensions, portal and stromal inflammatory changes, serum alanine and aspartate aminotransferases, renal indices, and oxidative stress markers. Three evidence-interpretation tables and two conceptual diagrams are provided. The presentation supplied by the investigator describes a prospective study design, not completed experiments: animal characteristics, lithogenic induction method, environmental agent, biocorrector, exposure duration, and measured outcomes are not yet specified. Accordingly, the present article does not report original efficacy estimates or statistical significance. The proposed integrated approach may facilitate hypothesis testing while avoiding attribution of systemic or hepatic changes to nephrolithiasis without appropriate controls.

References

1. Khan SR, Pearle MS, Robertson WG, et al. Kidney stones. Nat Rev Dis Primers. 2016;2:16008. doi:10.1038/nrdp.2016.8.

2. Khan SR. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol. 2014;3(3):256–276. doi:10.3978/j.issn.2223-4683.2014.06.04.

3. Evan AP. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol. 2010;25:831–841. doi:10.1007/s00467-009-1116-y.

4. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115(10):2598–2608. doi:10.1172/JCI26662.

5. Sadullayeva LE. Ekologik omillar ta’sirida kechuvchi tajribaviy buyrak-tosh kasalligida jigarning morfofunksional o‘zgarishlari va uning biokorreksiyasi. Doctoral research presentation, 8 slides. Unpublished author-provided material.

6. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172(3):367–379. doi:10.1503/cmaj.1040752.

7. Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112:18–35. doi:10.1038/ajg.2016.517.

8. Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi:10.1371/journal.pbio.3000410.

9. Lazic SE. The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis? BMC Neurosci. 2010;11:5. doi:10.1186/1471-2202-11-5.

10. Rule AD, Lieske JC, Li X, Melton LJ III, Krambeck AE, Bergstralh EJ. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014;25(12):2878–2886. doi:10.1681/ASN.2013091011.

11. Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192(2):316–324. doi:10.1016/j.juro.2014.05.006.

12. Fink HA, Wilt TJ, Eidman KE, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians clinical guideline. Ann Intern Med. 2013;158(7):535–543. doi:10.7326/0003-4819-158-7-201304020-00005.

13. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 5th ed. Oxford University Press; 2015.

14. Bancroft JD, Gamble M, editors. Theory and Practice of Histological Techniques. 7th ed. Churchill Livingstone Elsevier; 2013.

15. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412. doi:10.1371/journal.pbio.1000412.

Published

2026-10-17